Skip to content

Efficacy and Mechanism of Vaginal Microbiota Transplantation in the Treatment of Recurrent Vaginitis

Efficacy and Mechanism of Vaginal Microbiota Transplantation in the Treatment of Recurrent Vaginitis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100972
Enrollment
Unknown
Registered
2025-04-17
Start date
2025-04-17
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent Vaginitis

Interventions

Vaginal microbiota transplantation group:Vaginal microbiota transplantation

Sponsors

Changsha Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Female patients aged 18 to 50; 2. At least four or more episodes of vaginitis have occurred within the past year; 3. Sign the informed consent form, voluntarily participate in the research and accept follow-up.

Exclusion criteria

Exclusion criteria: 1. Pregnant or breastfeeding women; 2. Patients with severe immunodeficiency or serious organ diseases; 3. Patients who have received vaginal microbiota transplantation or similar treatments within the past three months; 4. Patients with other types of vaginal infections (e.g., trichomoniasis).

Design outcomes

Primary

MeasureTime frame
Structure of the vaginal microbiota;Recurrence rate;Vaginal pH;

Secondary

MeasureTime frame
Clinical symptom scores (e.g., vaginal discharge, itching, odor);

Countries

China

Contacts

Public ContactHuang Lihui

Changsha Maternal and Child Health Hospital

516453371@qq.com+86 136 3742 4928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026